NIFTY
74.25  0.64%
 11662.60
S&P BSE SENSEX
234.33  0.60%
 39131.04
Sun Pharmaceutical Industries Ltd.
NSE : SUNPHARMA BSE : 524715 ISIN code : INE044A01036
on 16-Jul-2019
NSE
10.35    2.45%
Rs. 433.30
 
Days Low
Rs. 418.75
Days High
Rs. 434.95

Open Rs. 421.3
 
52 week Low
Rs. 350.4
52 week High
Rs.678.8
 
 
Bid :                 433.25 (225)
Offer :        0.00 (0)
BSE
Rs.433.25
10.85    2.57%
on 16-Jul-2019
BSE
10.85    2.57%
Rs. 433.25
 
Days Low
Rs. 418.65
Days High
Rs. 435

Open Rs. 420.8
 
52 week Low
Rs. 344.55
52 week High
Rs.679.3
 
 
Bid :                 433.25 (225)
Offer :        0.00 (0)
NSE
Rs.433.30
10.35    2.45%
 
 
Last Price (Rs.)  433.25 Value  216418326.00
Net Change (Rs.)  10.85 Best Buy  433.25
Volume  506834 Best Sell  0.00
Prev.Close (Rs.)  422.40 Best Quantity  225
Open (Rs.)  421.30 Sell Quantity  0
High (Rs.)  434.95 52-Week High (Rs.)  678.80
Low (Rs.)  418.75 52-Week Low (Rs.)  350.40
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  1039511.88
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Share Capital2399.30 2399.30 2406.60 
Currents Investments447.60 400.10 735.60 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Cipla 553.60 446107 195.85 30.35 0.54
Dr. Reddys Lab 2677.85 444828 758.80 34.80 0.75
Divis Lab 1647.70 437413 262.68 50.30 0.97
Piramal Enterprises 2036.80 405011 1176.18 0.00 1.37
Ranbaxy Labs. 859.90 366028 1.53 0.00 0.00
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Mar 2019Dec 2018Sep 2018
Net Sales25521.3022612.6022992.50
Operating Profit12377.302023.705926.10
PBDT11183.60689.90-7731.50
Net Profit10680.60-386.80-9064.20
More> 
 
Company News
7/15/2019 12:00:00 AM
Announcement under Regulation 30 (LODR)-Press Release / Media Release
7/15/2019 12:00:00 AM
Sun Pharma, BHEL and KDDL to see some action today
7/15/2019 12:00:00 AM
Sun Pharma launches Ezallor Sprinkle capsules in US
More>
 
Ratios
   Earnings Per Share (Rs)-2.06 
   Book NAV/Share(Rs)82.40 
   PAT Margin (%)-6.22 
   Asset Turnover(x)0.23 
   PER(x)0.00 
   Yield(%)0.40 
   EV/Core EBITDA(x)100.39 
   M Cap / Sales15.00 
   Net Sales Growth(%)3.12 
   PAT Growth(%)-2065.46 
   Total Debt/Equity(x)0.35 
   Current Ratio(x)0.56 
   Quick Ratio(x)0.39 
   Total Debt/Mcap(x)0.06 
More>